Synthesis and anti-inflammatory activity of 2-(2-aroylaroxy)-4,6-dimethoxy pyrimidines

Bioorganic and Medicinal Chemistry Letters

Volumn 18, Issue 15, 2008, Pages 4409-4412

  Venu, T D ^a   Khanum, S A ^b   Firdouse, Aiysha ^b   Manuprasad, B K ^a   Shashikanth, Sheena ^a   Mohamed, Riyaz ^a   Vishwanth, Bannikuppe Sannanaik ^a  

^a UNIVERSITY OF MYSORE   (India)

^b UNIVERSITY OF MYSORE   (India)

Author keywords

Anti inflammatory activity; Pyrimidines; Synthesis

Indexed keywords

2 (2 AROYLAROXY) 4,6 DIMETHOXYPYRIMIDINE; PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; MASS SPECTROMETRY; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; RAT;

ALGORITHMS; ANIMALS; ANIMALS, INBRED STRAINS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DISEASE MODELS, ANIMAL; EDEMA; FOOT; MICE; PHOSPHOLIPASES A2; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRIMIDINES; RATS; ULCER;

EID: 47749124930     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2008.06.061     Document Type: Article

References (25)

1. Palomer A., Perez J.J., Navea S., Llorens O., Pascual J., Garcia M.L., and Mauleon D.M. J. Med. Chem. 43 (2000) 2280
2. Palomer A., Pascual J., Cabre M., Borras L., Gonzalez G., Aparici M., Carabaza A., Cabre F., Garcia M.L., and Mauleon D. Bioorg. Med. Chem. Lett. 12 (2002) 533
3. Jiri J., Miroslav P., Josef P., and Stanislav W. Csech CS 271 (1991) 185 through Chem. Abstr. 1992, 117, 170994d
4. Brideau C., Kargman S., liu S., Dallob A.L., Ehrich E.W., Rodger I.W., and Chan C.C. Inflammation Res. 45 (1996) 68
5. Williams M., Kowaluk E.A., and Arneric S.P. J. Med. Chem. 42 (1999) 1481
6. Ottosen E.R., Sorensen M.D., Bjorkling F., Skak-Nielsen T., Fjording M.S., Aaes H., and Binderup L. J. Med. Chem. 46 (2003) 5651
7. Khanum S.A., Shashikanth S., and Deepak A.V.. Bioorg. Chem. 32 (2004) 211
8. Khanum S.A., Murari S.K., Vishwanth B.S., and Shashikanth S. Bioorg.Med. Chem. Lett. 15 (2005) 4100
9. Chabner B.A., Wilson W., and Supko J. Pharmocology and Toxicity of Anti-neoplastic Drugs. In: Beutler E., Lichtman M.A., Coller B.S., Kipps T.J., and Seligsohn U. (Eds). William Hematology. sixth ed. (2001), McGraw-Hill, New York 185
10. Hardman J.G., Limbird L.E., Molinoff P.B., Ruddon R.W., and Gilman A.G. In: Goodman, and Gilman's (Eds). The Pharmacological Basics of Therapeutics. Tenth International ed. (2001), McGraw-Hill, New York 1404
11. Brown D.J. Pyrimidines and their Benzo Derivatives. In: Katritzky A.R., and Rees C.W. (Eds). Comprehensive Heterocyclic Chemistry. The Structure, Reactions, Synthesis and Uses of Heterocyclic Compounds vol. 3 (1984), Pergamon Press, Oxford 57
12. Nasr M.N., and Gineinah M.M. Arch. Pharm. (Weinheim) 335 (2002) 289
13. Bartolome-Nebreda J.M., Garcia-Lopez M.T., and Gonzalez-Muniz. J. Med. Chem. 24 (2001) 4196
14. Santagati A., Granata G., Santagati M., Cutuli V., Mangano M.G., and Caruso A. Arznei-Forsch 52 (2002) 448
15. Unangst C.P., Connor D.T., Kostlan C.R., and Shrum G.P.J. Heterocycl. Chem. 32 (1995) 1197
16. Tozkoparan B., Ertan M., Kelicen P., and Demirdamar R. Il Farmaco 54 (1999) 588
17. 4: C, 50.75; H, 3.14; Br, 17.77; Cl, 7.88; N, 6.23. Found: C, 50.68; H, 3.07; Br, 17.69; Cl, 7.80; N, 6.18%.
18. Winter C.A., Risley E.A., and Nuss G.W. Proc. Soc. Exp. Biol. NY 111 (1962) 544
19. Djahanguiri B. J. Pharm. Pharmacol. 21 (1969) 541
20. Smith Q.E. J. Pharmacol. Exp. Ther. 100 (1950) 408
21. Calderano V., Parrillo C., and Grovane A. J. Pharmacol. Exp. Ther. 263 (1992) 579
22. Vishwanath B.S., Frey F.J., Eischer G., Reichen J., and Frey B.M.J. Clin. Invest. 98 (1996) 365
23. Fox N., Song M., Schermenti J., Sharp J.D., White D.L., Snyder D.W., Hartley L.W., Carlson D.G., Bach N.J., Dillard R.D., Draheim S.E., Bobbit J.L., Fisher L., and Mihelich E.D. Eur. J. Pharmacol. 308 (1996) 195
24. Glaser K.B. Adv. Pharmacol. 32 (1995) 31
25. Mayer R.J., and Marshall L.A. FASEB J7 (1993) 339